- Home
- RSLS vs ADIL Comparison
RSLS vs ADIL Comparison
Compare RSLS & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- ADIL
- Stock Information
- Founded
- RSLS 2002
- ADIL 2010
- Country
- RSLS United States
- ADIL United States
- Employees
- RSLS N/A
- ADIL N/A
- Industry
- RSLS Medical/Dental Instruments
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- RSLS Health Care
- ADIL Health Care
- Exchange
- RSLS Nasdaq
- ADIL Nasdaq
- Market Cap
- RSLS 4.5M
- ADIL 4.3M
- IPO Year
- RSLS 2007
- ADIL 2018
- Fundamental
- Price
- RSLS $4.31
- ADIL $0.70
- Analyst Decision
- RSLS Hold
- ADIL Strong Buy
- Analyst Count
- RSLS 1
- ADIL 1
- Target Price
- RSLS N/A
- ADIL $8.00
- AVG Volume (30 Days)
- RSLS 101.4K
- ADIL 1.4M
- Earning Date
- RSLS 05-21-2025
- ADIL 05-15-2025
- Dividend Yield
- RSLS N/A
- ADIL N/A
- EPS Growth
- RSLS N/A
- ADIL N/A
- EPS
- RSLS N/A
- ADIL N/A
- Revenue
- RSLS $7,175,000.00
- ADIL N/A
- Revenue This Year
- RSLS $52.80
- ADIL N/A
- Revenue Next Year
- RSLS N/A
- ADIL N/A
- P/E Ratio
- RSLS N/A
- ADIL N/A
- Revenue Growth
- RSLS N/A
- ADIL N/A
- 52 Week Low
- RSLS $4.03
- ADIL $0.57
- 52 Week High
- RSLS $414.99
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- RSLS 34.73
- ADIL 51.88
- Support Level
- RSLS $4.34
- ADIL $0.65
- Resistance Level
- RSLS $4.95
- ADIL $0.74
- Average True Range (ATR)
- RSLS 0.53
- ADIL 0.06
- MACD
- RSLS 0.19
- ADIL 0.00
- Stochastic Oscillator
- RSLS 10.11
- ADIL 68.29
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.